Filing Details

Accession Number:
0001179110-11-010855
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-11 17:50:11
Reporting Period:
2011-07-07
Filing Date:
2011-07-11
Accepted Time:
2011-07-11 17:50:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1308911 E John Bishop 675 West Kendall Street
Cambridge MA 02142
Senior Vp, Pharmaceutical Scie No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-07-07 4,987 $20.92 98,321 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase stock Acquisiton 2011-07-07 4,987 $10.43 4,987 $10.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,343 2009-05-25 2019-02-25 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2009.